Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulsed-field Catheter Ablation as the First-line Treatment for Asymptomatic Non-paroxysmal Atrial Fibrillation

NCT06166524 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT06166524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06166524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulsed-field Catheter Ablation as the First-line Treatment for Asymptomatic Non-paroxysmal Atrial Fibrillation
Lead sponsor
Charles University, Czech Republic
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 1, 2024
Completion date
December 31, 2025
Enrollment
124 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, functional exercise testing, pulsed-field ablation